Patrick Salmon

After qualifying as a physician Patrick Salmon spent several years in clinical medicine later entering the area of clinical research.

While working for Contract Research Organisation in Ireland and the UK, Patrick organised and ran phase 1, 2, and 3 studies. After a short period working with a pharmaceutical company, he joined the Irish regulatory agency in 1994 and has worked there since, assessing medical aspects of all types of applications.

His areas of involvement include clinical trial assessment; mutual recognition and decentralised applications; and centralised applications.

In 2000, Patrick became a member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA). Later in 2004, he became an Irish delegate on the Committee for Orphan Medicinal Products (COMP) also at the EMA.

Additional interests include Product Information and he is Chair of the CHMP ad hoc group on the SmPC (Summary of Product Characteristics) and the CMD(h) (Co-ordination group for Mutual Recognition and Decentralised Procedures (human)) subgroup on harmonisation of the SmPC.

www.imb.ie

 
 
La voix des patients atteints de maladies rares en EuropeEURORDIS Donnant la voix, à l'international, aux personnes vivant avec une maladie rareRare Disease International Pour rapprocher patients, familles et experts sur un forum modéré multilingue, où partager leurs expériences. RareConnect Le programme Rare Barometer est une initiative d’EURORDIS qui vise à réaliser des sondages pour transformer les expériences des patients de maladie rare en faits et chiffres à communiquer aux décideurs politiques.Rare Barometer Campagne internationale de sensibilisation organisée chaque année le dernier jour de février, la Journée Internationale des Maladies Rares est une initiative d'EURORDISRare Disease Day Participez au plus grand événement réunissant tous les acteurs des maladies rares en Europe lors de Conférence européenne bisannuelle sur les maladies rares et les médicaments orphelins (European Conference on Rare Diseases and Orphan Products, ou ECRD). L'ECRD est une initiative d'EURORDISEuropean Conference on Rare Diseases